Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine.

Philip Milam, Michael Berger, Bhuvaneswari Ramaswamy, Raquel Reinbolt, Robert Wesolowski, Benjamin H Kaffenberger

Open access · greenAbstract readCase Reports

In one paragraph

Article in The Journal of clinical and aesthetic dermatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

0.2field-weighted citation impact, top 41% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database.Breast cancer research : BCR · 2025
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Philip MilamDrs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

Michael BergerDrs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

Bhuvaneswari RamaswamyDrs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

Raquel ReinboltDrs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

Robert WesolowskiDrs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

Benjamin H KaffenbergerDrs. Milam and Kaffenberger are with the Division of Dermatology at The Ohio State University Wexner Medical Center in Columbus, Ohio.

The Ohio State University Wexner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ado-trastuzumab emtansinecirrhosismetastatic breast cancernodular regenerative hyperplasiapalmar flushingpseudocirrhosisT-DM1telangiectasia

Identifiers

PMID31531159

PMCPMC6715332

OpenAlexW2981281519

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.